Related Stories
Quotations
Last week, Christine Jacobs, the CEO of Theragenics Corp., a public company listed on the New York Stock Exchange that makes medical devices and is involved in cutting-edge cancer cures, wrote a letter to President Obama explaining why it was necessary to "begin moving our U.S. manufacturing to Costa Rica."
As Ms. Jacobs explains: "Our products are for people with prostate cancer, heart disease, breast cancer and orthopedic knee or hip surgeries. Our 626 employees' futures are now uncertain. The cost of regulation, legislation and now the Device Tax have provided an atmosphere that is close to untenable."
